Bernard F. Tobin
2016
In 2016, Bernard F. Tobin earned a total compensation of $2.7M as President, Crescendo Bioscience, Inc at Myriad Genetics.
Compensation breakdown
| Bonus | $192,092 |
|---|---|
| Salary | $412,000 |
| Stock Awards | $2,119,000 |
| Other | $11,433 |
| Total | $2,734,525 |
Tobin received $2.1M in stock awards, accounting for 77% of the total pay in 2016.
Tobin also received $192.1K in bonus, $412K in salary and $11.4K in other compensation.
Rankings
In 2016, Bernard F. Tobin's compensation ranked 3,558th out of 14,075 executives tracked by ExecPay. In other words, Tobin earned more than 74.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,558 out of 14,075 | 75th |
Division Manufacturing | 1,238 out of 5,489 | 77th |
Major group Chemicals And Allied Products | 374 out of 1,895 | 80th |
Industry group Drugs | 272 out of 1,538 | 82nd |
Industry In Vitro and In Vivo Diagnostic Substances | 5 out of 65 | 92nd |
Source: SEC filing on October 11, 2016.
Tobin's colleagues
We found four more compensation records of executives who worked with Bernard F. Tobin at Myriad Genetics in 2016.